Epitope analysis of myeloperoxidase-(MPO) specific anti-neutrophil cytoplasmic autoantibodies (ANCA) in MPO-ANCA-associated glomerulonephritis

Clinical Nephrology

Volumn 53, Issue 4, 2000, Pages 242-252

  Fujii, A ^a,b   Tomizawa, K ^a   Arimura, Y ^b   Nagasawa, T ^b   Ohashi, Y Y ^a   Hiyama, T ^c   Mizuno, S ^a   Suzuki, K ^a  

^a NATIONAL INSTITUTE OF INFECTIOUS DISEASES   (Japan)

^b KYORIN UNIVERSITY   (Japan)

^c Grelan Pharmaceutical Co Ltd   (Japan)

Author keywords

Anti neutrophil cytoplasmic autoantibodies (ANCA) MPO ANCA; Epitope analysis; Glomerulonephritis; Myeloperoxidase; Neutrophils

Indexed keywords

MYELOPEROXIDASE; NEUTROPHIL CYTOPLASMIC ANTIBODY;

ADULT; AGED; ANTIBODY SPECIFICITY; ANTIGEN RECOGNITION; ARTICLE; CLINICAL ARTICLE; FEMALE; GENETIC PREDISPOSITION; GLOMERULONEPHRITIS; HLA TYPING; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOBLOTTING; INCIDENCE; LUNG FIBROSIS; MALE; MOLECULAR RECOGNITION; PATHOGENESIS;

ADULT; AGED; AGED, 80 AND OVER; ANTIBODIES, ANTINEUTROPHIL CYTOPLASMIC; EPITOPE MAPPING; FEMALE; GLOMERULONEPHRITIS; HUMANS; MALE; MIDDLE AGED; PEROXIDASE;

EID: 0034038346     PISSN: 03010430     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Aizawa M 1986 Antigen and gene frequencies of ethnic groups. In: Aizawa M (ed) HLA in Asia-Oceania 1986. Hokkaido University Press, Sapporo, Japan, pp 1080-1081
2. Arimura Y, Minoshima S, Kamiya Y, Nakabayashi K. Kiyoshi K, Nagasawa T 1992 Localization of myeloperaxidase (MPO) in the glomeruli of patients with anti-MPO antibodies associated crescentic glomerulonephritis. J Kyorin Med Soc 23: 69-73
3. Arimura Y, Minoshima S, Kamiya Y, Nakabayashi K, Kiyoshi K, Nagasawa T, Sasaki T, Suzuki K 1993 Serum myeloperoxidase and serum cytokines in antimyeloperoxidase antibody-associated glomerulonephritis. Clin Nephrol 40: 256-264
4. Audrain MA, Baranger TA, Moguilevski N, Martin SJ, Devys A, Lockwood CM, Muller JY, Esnault VL 1997 Anti-native and recombinant myeloperoxidase monoclonals and human autoantibodies. Clin Exp Immunol 107: 127-134
5. Ballieux BE, Zondervan KT, Kievit P, Hagen EC, van Es LA, van der Woude FJ, Daha MR 1994 Binding of proteinase 3 and myeloperoxidase to endothelial cells: ANCA-mediated endothelial damage through ADCC? Clin Exp Immunol 97: 52-60
6. 4. J Immunol 149: 1409-1415
7. Brouwer E, Stegeman CA, Huitema MG, Limburg PC, Kallenberg CG 1994a T cell reactivity to proteinase 3 and myeloperoxidase in patients with Wegener's granulomatosis (WG). Clin Exp Immunol 98: 448-53
8. Brouwer E, Hustema MG, Mulder AH et al 1994b neutrophil activation in vitro and in vivo in Wegener's granulomatosis. Kidney Int 48: 801-805
9. Chang L, Binos S, Savige J 1995 Epitope mapping of anti-proteinase 3 and anti-myeloperoxidase antibodies. Clin Exp Immunol 102: 112-119
10. Cohen TJW, Goldschmeding R, Elema JD, van der Giessen M, Huitema MG, van der Hem GK, The TH, von dem Borne A, Kallenberg CG 1990 Autoantibodies against myeloid lysosomal enzymes in crescentic glomerulonephritis. Kidney Int 37: 799-806
11. Cohen P, Guillevin L, Baril L, Lhote F, Noel LH, Lesavre P 1995 Persistence of antineutrophil cytoplasmic antibodies (ANCA) in asymptomatic patients with systemic polyarteritis nodosa or Churg-Strauss syndrome: follow-up of 53 patients. Clin Exp Rheumatol 13: 193-198
12. Derry CJ, Ross CN, Lombardi G, Mason PD, Rees AJ, Lechler RI, Pusey CD 1995 Analysis of T cell responses to the autoantigen in Goodpasture's disease. Clin Exp Immunol 100: 262-268
13. Falk RJ, Jennette JC 1988 Anti-neutrophil cytoplasmic autoantibodies with specificity for myeloperoxidase in patients with systemic vasculitis and idiopathic necrotizing and crescentic glomerulonephritis. N Engl J Med 318: 1651-1657
14. Falk RJ, Terrell RS, Charles LA, Jennette JC 1990 Anti-neutrophil cytoplasmic autoantibodies induce neutrophils to degranulate and produce oxygen radicals in vitro. Proc Natl Acad Sci USA 87: 4115-4119
15. Falk RJ, Becker M, Terrell R, Jennette JC 1992 Anti-myeloperoxidase autoantibodies react with native but not denatured myeloperoxidase. Clin Exp Immunol 89: 274-278
16. Gilligan HM, Bredy B, Brady HR, Hebert MJ, Slayter HS, Xu Y, Rauch J, Shia MA, Koh JS, Levine JS 1996 Antineutrophil cytoplasmic autoantibodies interact with primary granule constituents on the surface of apoptotic neutrophils in the absence of neutrophil priming. J Exp Med 184: 2231-2241
17. Hagen EC, Stegeman CA, D'Amaro J, Schreuder GM, Lems SP, Tervaert JW, de Jong GM, Hene RJ, Kallenberg CG, Daha MR et al 1995 Decreased frequency of HLA-DRI3DR6 in Wegener's granulomatosis. Kidney Int 48: 801-805
18. Hashinaka K, Nishio C, Hur SJ, Sakiyama F, Tsunasawa S, Yamada M 1988 Multiple species of myeloperoxidase messenger RNAs produced by alternative splicing and differential polyadenylation. Biochem 27: 5906-5914
19. Homma T, Suzuki K, Kudo Y, Inagawa M, Mizuno S, Yamaguchi E, Tagawa M 1989 Preparation and characterization of monoclonal antibodies against human myeloperoxidase. Arch Biochem Biophys 273: 189-196
20. Jayne DR, Gaskin G, Pusey CD, Lockwood CM 1995 ANCA and predicting relapse in systemic vasculitis. Q J Med 88: 127-133
21. Kettritz R, Jennette JC, Falk RJ 1997 Crosslinking of ANCA-antigens stimulates superoxide release by human neutrophils. J Am Soc Nephrol 8: 386-394
22. Laemmli UK 1970 Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227: 680-685
23. Luqmani RA, Bacon PA, Moots RJ, Janssen BA, Pall A, Emery P, Savage C, Adu D 1994 Birmingham vasculitis activity score (BVAS) in systemic necrotizing vasculitis. Q J Med 87: 671-678
24. Minoshima S, Arimura Y, Nakabayashi K, Kitamoto A, Nagasawa T, Ishida-Okawara A, Suzuki K 1997 Increased release of myeloperoxidase in vitro from neutrophils of patients with myeloperoxidase-specific antineutrophil cytoplasmic antibody (MPO-ANCA) related glomerulonephritis. Nephrology 3: 527-534
25. Nakamaru Y, Maguchi S, Takizawa M, Fukuda S, Inuyama T 1996 The association between human leukocyte antigen (HLA) and cytoplasmic-antineutrophil cytoplasmic antibody-(cANCA) positive Wegener's granulomatosis in Japanese population. Rhinology 34: 163-165
26. Okubo M, Kokubun M, Nishimaki T, Kasukawa R, Ohto H 1995 T cell epitope mapping of UI-A RNP. Arthritis Rheum 38: 1170-1172
27. Otani I, Ishida-Okawara A, Yamagoe S, Miyoshi-Koshio T, Arimura Y, Nagasawa T, Mizuno S, Suzuki K 1997 Myeloperoxidase fragments reacting with serum from a patient with myeloperoxidase-anti-neutrophil cytoplasmic antibody-positive glomerulonephritis. J Infect Chemother 3: 164-169
28. Pedrollo E, Bled L, Bautz FA, Kalden JR, Bautz EK 1993 Antineutrophil cytoplasmic antibodies (ANCA) recognizing a recombinant myeloperoxidase subunit. Adv Exp Med Biol 336: 87-92
29. Reumaux D, Vossebeld PJ, Roos D, Verhoeren AJ 1995 Effect of tumor necrosis factor-induced integrin activation on Fc gamma-receptor II-mediated signal transduction: relevance for activation of neutrophils by anti-proteinase 3 or anti-myeloperoxidase antibodies. Blood 86: 3189-3195
30. Saeki T, Kuroda T, Morita T, Suzuki K, Arakawa, M, Kawasaki K 1995 Significance of myeloperoxidase in rapidly progressive glomerulonephritis. Am J Kidney Dis 26: 13-21
31. Short AK, Lockwood CM, Bollen A, Moguilevsky N 1995 Neutrophil and recombinant myeloperoxidase as antigens in ANCA-positive systemic vasculitis. Clin Exp Immunol 102: 106-111
32. Suzuki K, Yamada M, Akashi K, Fujikura T 1986 Similarity of kinetics of three types of myeloperoxidase from human leukocytes and four types from HL-60 cells. Arch Biochem Biophys 245: 167-173
33. Tomizawa K, Mine E, Fujii A, Ohasi Y, Yamagoe S, Hashimoto Y, Ishida, Okawara A, Ito M, Tanokura M, Yamamoto T, Arimura Y, Nagasawa T, Mizuno S, Suzuki K 1998 A panel set for epitope analysis of meyloperoxidase-(MPO) specific antineutrophil cytoplasmic antibody MPO-ANCA using recombinant hexamer histidine-tagged MPO deletion mutants. J Clin Immunol 18: 142-152